Human prolactin (lactogenic hormone) is secreted from the anterior pituitary gland in samples. Human prolactin is a single chain polypeptide hormone with a molecular weight of approximately 23,000 daltons.2 The release and synthesis of prolactin is under neuroendocrinal control, primarily through Prolactin Releasing Factor and Prolactin Inhibiting Factor.3
Some samples normally have slightly higher basal prolactin levels than other samples; apparently there is an estrogen-related rise at puberty and a corresponding decrease at menopause. The primary functions of prolactin are to initiate breast development and to maintain lactation. Prolactin also suppresses gonadal function.4,5 During pregnancy, prolactin levels increase progressively to between 10 and 20 times of normal values, declining to nonpregnant levels by 3-4 weeks post-partum.4 Breast-feeding mothers maintain high levels of prolactin, and it may take several months for serum concentrations to return to non-pregnant levels.3,4
The determination of prolactin concentration is helpful in researching hypothalamic-pituitary disorders.3,4 Microadenomas (small pituitary tumors) may cause hyperprolactinemia, which is sometimes associated with sample impotence.6 High prolactin levels are commonly associated with galactorrhea and amenorrhea.5
Prolactin concentrations have been shown to be increased by estrogens, thyrotropin-releasing hormone (TRH), and several drugs affecting dopaminergic mechanisms.7,8,9,10 Prolactin levels are elevated in renal disease and hypothyroidism, and in some situations of stress, exercise, and hypoglycemia. Additionally, the release of prolactin is episodic and demonstrates diurnal variation.5 Mildly elevated prolactin concentrations should be evaluated taking these considerations into account. Prolactin concentrations may also be increased by drugs such as chloropromazine and reserpine, and may be lowered by bromocyptine and L-dopa.4
The Aviva Prolactin Enzyme Immunoassay provides a rapid, sensitive, and reliable assay for the measurement of prolactin. The antibodies developed for the test will determine a minimal concentration of human prolactin of 2 ng/ml. There is no crossreactivity with hCG, TSH, LH, FSH, or hGH.
Enzyme Immunoassay for the Quantitative Determination of Prolactin in Serum
Principle of the assay: The Aviva Prolactin Quantitative Test is based on the principle of a solid phase enzyme-linked immunosorbent assay.11,12 The assay system utilized mouse monoclonal anti-prolactin for solid phase (microtiter wells) immobilization and another mouse monoclonal anti-prolactin in the antibody-enzyme (horseradish peroxidase) conjugate solution. The test sample is allowed to react simultaneously with the antibodies, resulting in the prolactin molecules being sandwiched between the solid phase and enzymelinked antibodies. After a 45 minute incubation at room temperature, the wells are washed with water to remove unbound labeled antibodies. A solution of Tetramethylbenzidine (TMB) is added and incubated for 20 minutes, resulting in the development of a blue color. The color development is stopped with the addition of 1N HCl, and the resulting yellow color is measured spectrophotometrically at 450 nm. The concentration of prolactin is directly proportional to the color intensity of the test sample.